XClinical To Present End-to-End Clinical Process

Main Category: Clinical Trials / Drug Trials
Also Included In: IT / Internet / E-mail
Article Date: 02 Jun 2009 - 0:00 PDT

email to a friend   printer friendly   opinions  

XClinical, a European vendor of innovative software products for eClinical trials, is presenting CDISC based tools for an End-To-End clinical process at the 45th DIA Annual Meeting in San Diego, USA.

At the Annual Meeting "Better Medicines: Improving Safety with Every Step", taking place in San Diego on June 21st to June 25th 2009, the Drug Information Association is providing a meeting area for more than 8,900 professionals from over 800 exhibiting companies and more than 50 countries. 350 speaking sessions and three mega tracks are dealing with topics related to medical communications, clinical research and information technology.

In addition to XClinical's participation as exhibitor, Dr. Claus Lindenau, Head of Business Development, is going to be speaker at the session "CDISC SDTM Data Conversion: Reusability and Repeatability". The presentation will review the typical data transformation process to obtain CDISC SDTM and will compare advantages and disadvantages of using SAS code versus tools that use the CDISC XML based metadata. "Using tools that automatically generate mapping rules can speed up the process of validation since the generic mechanism of automatic rule generation needs to be validated only once and does not need to be completely repeated for every single trial." Said Dr. Lindenau. "Those mechanisms help to reduce costs and to avoid time delays, which you're facing using SAS programs to transform data from clinical trials to CDISC SDTM."

To get an insight on the standardization of the data transformation process, attend one of XClinical's presentations of CDISC based tools for an End-To-End clinical process at booth # 1426.

Source
XClinical

• Additional
• References
• Citations